  Second primary malignancy ( SPM) is a severe issue for cancer survivors , particularly for osteosarcoma ( OS) survivors. To date , the associations between subsequent SPM and OS have been well reported. Hematogenic and solid malignancies tend to occur following OS treatment. Reportedly , 2- (